ANDREA LACHNIET: Open Payments
NPI 1740739200 · BOZEMAN, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 22 payments from 8 companies in 2025. Trend: 2023 $626 · 2024 $321 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $169 |
| PFIZER INC. | 8 | $135 |
| Ipsen Biopharmaceuticals, Inc | 1 | $35 |
| Merz Pharmaceuticals, LLC | 1 | $32 |
| Celgene Corporation | 2 | $31 |
| CSL Behring | 1 | $30 |
| Lilly USA, LLC | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: AUSTEDO XR, NURTEC ODT, Dysport, Xeomin, ZEPOSIA, Hizentra, KISUNLA, KESIMPTA.
Industry payments across MT — which companies pay providers there.
